Form 4: Amneal Pharmaceuticals Executive Vice President Nikita Shah Sells $372,000 in Company Stock

Nikita Shah, Executive Vice President of Amneal Pharmaceuticals, sold 49,140 shares of Class A Common Stock at an average price of $7.58 on May 16, 2025.

Summary

• On May 16, 2025, Nikita Shah, an Executive Vice President at Amneal Pharmaceuticals, sold 49,140 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $7.58 per share.
• The prices for individual transactions ranged from $7.48 to $7.63 per share.
• Following the transaction, Nikita Shah directly owns 388,929 shares of Amneal Pharmaceuticals.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by an executive. It doesn't inherently convey positive or negative sentiment, but insider sales can sometimes be interpreted cautiously by investors.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is common in the pharmaceutical industry. Investors often monitor these filings for insights into management's perspective on the company's stock and future prospects. However, without additional context, it's difficult to determine the specific reasons behind the sale.

Stakeholder Impact

• The stock sale by an executive could have a minor impact on shareholder sentiment.

Key Dates

Keywords

Amneal Pharmaceuticals, Nikita Shah, AMRX, Executive Vice President, Stock Sale, Form 4, SEC Filing, Class A Common Stock